Avantor, Inc. (AVTR): EBITDA
$164.00M
Year ended 2025-12-31
$121.40M
Trailing 12 months to 2026-03-31
-52.6%
3-year compound annual growth
-31.7%
5-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $164.00M | -89.0% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $1.49B | +35.6% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $1.10B | -28.5% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $1.54B | +13.6% | 2025-02-07, From 2022-01-01 |
| 2021-12-31 | $1.35B | +22.6% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $1.10B | +15.9% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $950.70M | +16.2% | 2022-02-11, From 2019-01-01 |
| 2018-12-31 | $818.10M | n/m | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | -$111.20M | n/a | 2020-02-14, From 2017-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 2025-12-31 | $164.00M | -89.0% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.77B | +1.3% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.08B | n/m |
| Bruker Corp (BRKR) | 2025-12-31 | $288.50M | -34.0% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $761.98M | -1.6% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $212.60M | -49.5% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$24.79M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$32.80M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$109.70M | n/m |
Compare AVTR, A, ILMN, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗